Aspartame: Weight Loss & Heart/Brain Risks?

by Grace Chen

Aspartame Linked to Heart and Brain Damage in New Research, Raising Concerns Over ‘Zero’ drink Safety

A growing body of evidence suggests long-term consumption of aspartame, a widely used artificial sweetener found in diet sodas and other products, may pose significant risks to cardiovascular and cognitive health. New research, published in the journal Biomedicine & Pharmacotherapy in January 2026, adds to existing concerns about the popular sugar substitute.

The Allure of ‘Zero’ and the Hidden Costs

Aspartame is often marketed as a healthier alternative to sugar, especially for individuals seeking to reduce their calorie intake or manage blood sugar levels. This makes it a frequent recommendation for individuals managing diabetes or pre-diabetes. Such as, a 355ml serving of regular cola contains 140 calories and 39 grams of added sugar, while the same amount of Coke Zero contains zero calories and zero grams of added sugar. Though, this perceived benefit may come at a hidden cost.

Research Reveals Alarming Effects on Organ Function

A joint research team from CIC biomaGUNE in Spain and Biogipuzkoa HRI conducted a year-long study on mice, revealing concerning side effects associated with aspartame consumption. Mice were administered an amount of aspartame equivalent to one-sixth of the maximum allowable daily intake for humans (50 mg/kg), translating to approximately 7 mg per kg of body weight – 17.5% of the currently recommended daily amount of 40 mg.

Despite a 20% reduction in body weight among the test subjects, detailed analysis – including positron emission tomography (PET), magnetic resonance imaging (MRI), and cognitive testing – revealed a range of adverse effects. Researchers found a roughly 20% increased risk of mild cardiac hypertrophy, or thickening of the heart muscle. Cardiac output decreased in both ventricles, with the left ventricle experiencing a 26% reduction and the right ventricle a 20% decrease. The curvature of the interventricular septum,the wall dividing the heart’s chambers,also diminished by 25%.

Moreover,the study indicated cognitive decline in the aspartame-exposed rats,including impaired spatial perception and memory.

WHO Classification and cancer Risk

Thes findings add to existing concerns regarding aspartame’s safety. The International Agency for Research on Cancer (IARC), under the World Health Institution (WHO), has classified aspartame as a Group 2B carcinogen – a substance that can cause cancer in humans. While this classification doesn’t definitively mean aspartame will cause cancer, it highlights a potential risk, particularly with high consumption levels. A 2022 study involving 102,865 participants found a 13% higher cancer risk among those who consumed large amounts of artificial sweeteners, including aspartame.

Impact on Blood Sugar and Cognitive Health

Contrary to popular belief, research suggests aspartame may not effectively control blood sugar levels. Regular consumption could possibly reduce the body’s sensitivity to insulin, the hormone responsible for regulating blood sugar. Though, research in this area remains contradictory, necessitating further investigation.

Beyond blood sugar,studies indicate a potential link between artificial sweeteners like aspartame and detrimental effects on cognitive health,potentially through increased oxidative stress. A 2017 study of approximately 3,000 individuals revealed that those who consumed more than one artificially sweetened beverage daily had nearly three times the risk of developing dementia compared to non-consumers. A separate 2022 study of over 100,000 people linked artificial sweetener consumption to an increased risk of heart disease, with aspartame specifically associated with a 17% higher risk of stroke.

Calls for Re-Evaluation of Intake Guidelines

“We have confirmed that long-term exposure to aspartame can have detrimental effects on the function of major organs in the body, even at very low doses,” researchers stated, emphasizing the need for a critical review of current intake guidelines.The accumulating evidence suggests a more cautious approach to the widespread use of this artificial sweetener is warranted.

The full research paper can be found here: https://dx.doi.org/10.1016/j.biopha.2025.118891

You may also like

Leave a Comment